Jayne Sutherland News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The TB case-contact platform at the MRC Unit in The Gambia provides a unique opportunity for analysing immunity to TB across the spectrum of infection and disease. MRCG has been involved in several multi-site studies to define correlates of protective immunity to TB. However, until recently these have been mainly blood-derived. The establishment of bronchoscopy and single-cell RNA sequencing at MRCG has paved the way for identification of correlates of protection at the site of infection for rational development of next generation vaccines. 

The third day of World Immunisation Week will concentrate on Tuberculosis, focusing on vaccine development, progress, equity and clinical trials. The webinar, chaired by Toyin Togun from LSHTM, will include a presentation by Jayne Sutherland from LSHTM on TB vaccine development and Richard White from LSHTM on the contribution of TB vaccines to global TB control. 

On 24th March each year, the world commemorates the day in 1882 when Dr Robert Koch announced his discovery of Mycobacterium tuberculosis as the causative agent of tuberculosis.  We have taken this opportunity to host a one-day symposium March every year since 2010, to highlight contemporary TB research, control measures and policy initiatives, and to discuss future challenges. 

The screening, diagnosis, and treatment of tuberculosis (TB) in children remain far from optimal. Elri Voigt rounds up key developments in paediatric TB presented at the 52nd Union World Conference on Lung Health.

Elri Voigt rounds up five developments in paediatric TB presented at the 52nd Union World Conference on Lung Health.